Skip to Site Navigation Memorial Health System | Memorial Hospital for Children | Foundation | PhysicianLink  
 
Skip to the Site Area navigation  
 

Memorial Cancer and Genetic Counseling

Two genes have been identified as playing a significant role in developing breast cancer and/or ovarian cancer. These genes, called BRCA1 and BRCA2, control cell growth and division. Women who inherit either the BRCA1 or BRCA2 gene have a high probability of developing breast cancer and an increased risk of developing ovarian cancer.

There is a test for BRCA1 and BRCA2 mutations, however, it is preferable that testing begin with a family member who has had breast cancer. If a mutation is found, testing can be performed on other family members. It is best not to do the initial test on an unaffected individual because it may be difficult to interpret results.

The cost of the test can range between several hundred to several thousand dollars for the first person tested in a family. If a mutation is identified, testing subsequent individuals is less expensive.

There are major advantages of undergoing BRCA1 and BRCA2 testing, such as reducing uncertainty and the ability to appropriately increase or decrease cancer screening depending on the results of testing. However, the process of genetic testing may be emotionally difficult regardless of whether a mutation is found. Testing raises many important issues for women and their families, and our staff is available to discuss these issues and provide emotional and psychological support.

Genetic counseling is also available for colorectal cancer. For more information about genetic counseling, please contact our genetic counselors at (719) 365-5697 or (719) 365-5096.